Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Real World Evidence/RWE Solutions Market, by Region, 2020-2028 (USD Billion)
1.2.2. Real World Evidence/RWE Solutions Market, by Component, 2020-2028 (USD Billion)
1.2.3. Real World Evidence/RWE Solutions Market, by Therapeutic area, 2020-2028 (USD Billion)
1.2.4. Real World Evidence/RWE Solutions Market, by End Users, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Real World Evidence/RWE Solutions Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Real World Evidence/RWE Solutions Market Dynamics
3.1. Real World Evidence/RWE Solutions Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing geriatric population and the subsequent increase in the prevalence of chronic diseases
3.1.1.2. Increasing support from the regulatory bodies for the adoption of RWE solutions
3.1.2. Market Challenges
3.1.2.1. Lack of universal acceptance for methodological standards and data processing infrastructure
3.1.3. Market Opportunities
3.1.3.1. Growing focus on end-to-end RWE services
Chapter 4. Global Real World Evidence/RWE Solutions Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Real World Evidence/RWE Solutions Market, by Component
6.1. Market Snapshot
6.2. Global Real World Evidence/RWE Solutions Market by Component, Performance - Potential Analysis
6.3. Global Real World Evidence/RWE Solutions Market Estimates & Forecasts by Component 2019-2028 (USD Billion)
6.4. Real World Evidence/RWE Solutions Market, Sub Segment Analysis
6.4.1. Services
6.4.2. Data Sets
6.4.3. Clinical Setting Data
6.4.4. Claims Sata
6.4.5. Pharmacy Data
6.4.6. Patient Powered Data
Chapter 7. Global Real World Evidence/RWE Solutions Market, by Therapeutic area
7.1. Market Snapshot
7.2. Global Real World Evidence/RWE Solutions Market by Therapeutic area, Performance - Potential Analysis
7.3. Global Real World Evidence/RWE Solutions Market Estimates & Forecasts by Therapeutic area 2019-2028 (USD Billion)
7.4. Real World Evidence/RWE Solutions Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Cardiovascular
7.4.3. Neurology
7.4.4. Immunology
7.4.5. Others
Chapter 8. Global Real World Evidence/RWE Solutions Market, by End Users
8.1. Market Snapshot
8.2. Global Real World Evidence/RWE Solutions Market by End Users, Performance - Potential Analysis
8.3. Global Real World Evidence/RWE Solutions Market Estimates & Forecasts by End Users 2019-2028 (USD Billion)
8.4. Real World Evidence/RWE Solutions Market, Sub Segment Analysis
8.4.1. Pharmaceutical and Medical Devices Companies
8.4.2. Healthcare Providers
8.4.3. Healthcare Payers
8.4.4. Other End Users
Chapter 9. Global Real World Evidence/RWE Solutions Market, Regional Analysis
9.1. Real World Evidence/RWE Solutions Market, Regional Market Snapshot
9.2. North America Real World Evidence/RWE Solutions Market
9.2.1. U.S. Real World Evidence/RWE Solutions Market
9.2.1.1. Component estimates & forecasts, 2019-2028
9.2.1.2. Therapeutic area estimates & forecasts, 2019-2028
9.2.1.3. End Users estimates & forecasts, 2019-2028
9.2.2. Canada Real World Evidence/RWE Solutions Market
9.3. Europe Real World Evidence/RWE Solutions Market Snapshot
9.3.1. U.K. Real World Evidence/RWE Solutions Market
9.3.2. Germany Real World Evidence/RWE Solutions Market
9.3.3. France Real World Evidence/RWE Solutions Market
9.3.4. Spain Real World Evidence/RWE Solutions Market
9.3.5. Italy Real World Evidence/RWE Solutions Market
9.3.6. Rest of Europe Real World Evidence/RWE Solutions Market
9.4. Asia-Pacific Real World Evidence/RWE Solutions Market Snapshot
9.4.1. China Real World Evidence/RWE Solutions Market
9.4.2. India Real World Evidence/RWE Solutions Market
9.4.3. Japan Real World Evidence/RWE Solutions Market
9.4.4. Australia Real World Evidence/RWE Solutions Market
9.4.5. South Korea Real World Evidence/RWE Solutions Market
9.4.6. Rest of Asia Pacific Real World Evidence/RWE Solutions Market
9.5. Latin America Real World Evidence/RWE Solutions Market Snapshot
9.5.1. Brazil Real World Evidence/RWE Solutions Market
9.5.2. Mexico Real World Evidence/RWE Solutions Market
9.6. Rest of The World Real World Evidence/RWE Solutions Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Cognizant
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Oracle
10.2.3. ICON, plc.
10.2.4. PAREXEL International Corporation
10.2.5. Cerner Corporation
10.2.6. Flatiron Health
10.2.7. PerkinElmer
10.2.8. Anthem
10.2.9. Cegedim Health Data
10.2.10. SAS
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption